As Seen On TV, Inc. (fka ASTV)

[mick]

astv/ AirWare Labs and Breathe Active, LLC Announce Retail Agreement With Walmart
8:10a ET May 22, 2014 (Market Wire) Print
AirWare Labs Corp. (OTCQB: AIRW) and Breathe Active, LLC today announced Walmart will carry Breathe Active Sleep/Snore products in all of its 4,200 U.S. stores. Walmart has placed an initial order of 20,000 units to stock its stores' "As Seen On TV" shelves beginning in June.

Powered by AirWare's patented nasal insert technology, the Breathe Active Sleep/Snore increases airflow for better breathing and has been clinically proven to reduce snoring.

"This partnership with Walmart is a game changer," said Kevin Shaughnessy, President and CEO of Breathe Active, LLC. "Not only does it validate the product, but having the product available at all of Walmart's US stores allows Breathe Active's growing customer base to conveniently purchase the product for immediate use.

Offering our products through the nation's largest retailer allows us to reach a broad audience of consumers seeking to improve their health with better breathing."

"We are thrilled that Walmart shoppers will have the opportunity to access AirWare's proven nasal insert technology," said Jeffrey Rassas, CEO of AirWare Labs. "Breathe Active's demonstrated success in the Direct Response TV and

"As seen on TV" marketplace is testimony to the need for effective relief from sleep disorders."

AirWare Labs and Breathe Active, LLC recently announced expansion of their licensing agreement into Australia and New Zealand.

AirWare Labs also announced production of a branded video featuring TV and movie personalities Vincent Kartheiser (of AMC's drama Mad Men) and Adam Herschman, and disclosed plans for a sales and manufacturing expansion into China earlier this year.

AIR(R) ALLERGY was selected as a 2014 Visionary Award Finalist for the VISION(R) Consumer Products Conference in Dallas, and in 2013 AirWare Labs announced a national rollout into 7,500 Walgreen's stores.

About AirWare Labs Corporation:

AirWare Labs Corp. [publicly traded as (OTCQB: AIRW)] provides patented and innovative technology solutions for consumer products that promote better health through breathing and enhanced wellbeing. AirWare Labs' products are marketed under the brand name of AIR(R).

AIR(R) products utilize an FDA approved medical grade material, molded as an intranasal Air Breathe dilator, to act as the delivery system. This AIR(R) microstructure enhances normal nasal airflow with every breath -- clinically proven to deliver up to 40% more oxygen.

Some AIR(R) products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria.

AIR(R) Allergy and Travel products provide additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, allergens and bacteria. Other AIR(R) specialty products help provide and performance enhancements and relief from congestion, insomnia, headaches, nausea, and snoring.

For more product information, please visit: http://www.airwarelabs.com or company information visit: http://airwarelabscorp.com.

Forward-Looking Statement: The statements in this press release regarding any implied or perceived benefits from the release by AirWare Labs Corp. of its AIR(R) products are forward-looking statements. Such statements involve risks and uncertainties,

including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, and the ability to manage and continue growth.

Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.

Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC.

We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Media Contact:
Jennifer Breitegan
[e-mail]

Investor Relations:
Keith Pinder
Acorn Management
678-736-5682


SOURCE: AirWare Labs